NCT07699653

Brief Summary

The goal of this clinical trial is to compare three airway intubation devices in adult patients undergoing general anesthesia who require tracheal intubation. The main questions it aims to answer are:

  • Does the SPHJ-II video-assisted adjustable red-light fluoroscopic tracheal intubation scope improve first-attempt intubation success compared with a visual lighted stylet and a visual intubation fiberscope?
  • How do the three devices compare in intubation efficiency, intubation-related complications, and peri-intubation physiological responses? Researchers will compare the SPHJ-II, the visual lighted stylet, and the visual intubation fiberscope to evaluate their performance during tracheal intubation. Participants will be randomly assigned to one of the three device groups and undergo tracheal intubation during general anesthesia using the assigned device.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
549

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jul 2026Dec 2026

First Submitted

Initial submission to the registry

June 30, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 13, 2026

Status Verified

July 1, 2026

Enrollment Period

4 months

First QC Date

June 30, 2026

Last Update Submit

July 8, 2026

Conditions

Keywords

SPHI-IIVisual lighted styletVisual intubation fiberscopeFirst-attempt intubation successRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • First-attempt intubation success rate

    First-attempt intubation success is defined as successful tracheal intubation using the randomly assigned study device on the first attempt, with successful placement confirmed by the appearance of a sustained and regular end-tidal carbon dioxide waveform within 60 seconds of intubation attempt initiation.

    During the intubation procedure

Secondary Outcomes (8)

  • Intubation time

    During the intubation procedure

  • Number of intubation attempts

    During the intubation procedure

  • Incidence of hypoxemia

    During the intubation procedure

  • Incidence of airway-related complications

    During and immediately after the intubation procedure

  • Peri-intubation heart rate

    From baseline before induction to 2 minutes after successful tracheal intubation

  • +3 more secondary outcomes

Study Arms (3)

SPHJ-II group

EXPERIMENTAL

Participants randomized to this arm will undergo tracheal intubation using the SPHJ-II visual adjustable red-light tracheal intubation device after induction of general anesthesia.

Device: SPHJ-II

Video lighted stylet group

ACTIVE COMPARATOR

Participants randomized to this arm will undergo tracheal intubation using a video lighted stylet after induction of general anesthesia.

Device: Video lighted stylet

Visual intubation fiberscope group

ACTIVE COMPARATOR

Participants randomized to this arm will undergo tracheal intubation using a visual intubation fiberscope after induction of general anesthesia.

Device: Visual intubation fiberscope

Interventions

SPHJ-IIDEVICE

The SPHJ-II is a visual adjustable red-light tracheal intubation device used to facilitate endotracheal intubation after induction of general anesthesia.

SPHJ-II group

A video lighted stylet used to facilitate endotracheal intubation after induction of general anesthesia.

Video lighted stylet group

A visual intubation fiberscope used to facilitate endotracheal intubation after induction of general anesthesia.

Visual intubation fiberscope group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 65 years, inclusive. American Society of Anesthesiologists (ASA) physical status I to III. Scheduled for surgery under general anesthesia requiring endotracheal intubation.
  • The participant or legally authorized representative is fully informed of the purpose, methods, potential risks, and possible benefits of the study and provides written informed consent.

You may not qualify if:

  • Anticipated severe difficulty with mask ventilation, such as severe obesity (BMI \> 35 kg/m²) with obstructive sleep apnea syndrome, history of neck radiotherapy, craniofacial malformation, or other conditions judged by the attending anesthesiologist to confer high risk for mask ventilation, and patients requiring awake tracheal intubation.
  • Cervical spine instability, cervical trauma, rheumatoid arthritis involving the cervical spine, ankylosing spondylitis, or any condition requiring absolute cervical immobilization during the procedure.
  • Significant airway involvement identified preoperatively, including imaging evidence of tracheal narrowing with minimal diameter \< 5 mm, severe tracheal compression, displacement or collapse, stridor at rest or after activity, vocal cord paralysis with dyspnea, giant thyroid mass with orthopnea, or other oral, pharyngeal, or laryngeal tumor, edema, stenosis, abscess, or severe upper airway anatomical abnormality affecting glottic exposure or endotracheal tube passage.
  • High risk of reflux and aspiration. Severe cardiovascular disease, severe respiratory disease, severe hepatic or renal dysfunction, severe coagulation disorder, frailty, pregnancy or breastfeeding, or known allergy.
  • Any other condition making the patient unsuitable for participation in the study, such as psychiatric illness, communication disorder, or poor compliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Guangzhou, Guangdong, China

Location

Study Officials

  • Wuhua Ma, MD

    The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants are anesthetized during the intervention and are not informed of the assigned intubation device. The anesthesiologist performing tracheal intubation is not blinded because knowledge of the assigned device is necessary for the procedure. Postoperative follow-up personnel and outcome assessors responsible for data collection will remain blinded to treatment allocation whenever feasible.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective, randomized, three-arm parallel-group clinical trial. Eligible patients undergoing general anesthesia with endotracheal intubation will be assigned in a 1:1:1 ratio to intubation with the SPHJ-II visual adjustable red-light intubation device, a video lighted stylet, or a visual intubation fiberscope. Each participant will receive only one assigned intervention, and outcomes will be compared across the three groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 30, 2026

First Posted

July 13, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 13, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the study involves patient-level clinical data and no formal data-sharing plan has been established.

Locations